scispace - formally typeset
M

Md. Rezaul Islam

Researcher at German Center for Neurodegenerative Diseases

Publications -  89
Citations -  1453

Md. Rezaul Islam is an academic researcher from German Center for Neurodegenerative Diseases. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 9, co-authored 17 publications receiving 633 citations. Previous affiliations of Md. Rezaul Islam include University of Bordeaux & University of Engineering and Technology, Lahore.

Papers
More filters
Journal ArticleDOI

Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications

TL;DR: In this article , the potential biomedical applications of green synthesized zinc oxide nanoparticles (ZnO-NPs) have been investigated, which shows that they have outstanding potential as a potent biological agent, as well as related hazardous properties.
Journal ArticleDOI

The Multifunctional Role of Herbal Products in the Management of Diabetes and Obesity: A Comprehensive Review

TL;DR: An examination of plant-inferred compounds that might be utilized against heftiness or potentially hostile to diabetes treatments and an expanded comprehension of the systems of activity of phytogenic compounds could prompt the advancement of remedial methodologies for metabolic diseases.
Journal ArticleDOI

In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease.

TL;DR: This in silico study has conclusively predicted the superiority of the natural compound quercetin over the conventional drugs as AchE inhibitor and it sets the need for further in-vitro study of this compound in future.
Journal ArticleDOI

Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology.

TL;DR: A comprehensive review of the literature about traditional plants and their metabolites with their applications for the treatment of lung diseases through experimental models in humans is presented in this paper , where the results of the mentioned natural metabolites repurposed for different lung diseases especially for SARS-CoV-2 should be evaluated more by advance computational applications, experimental model in the biological system, also need to be validated by clinical trials so that we may be able to retrieve potential drugs for most challenging lung diseases.